Study on Cross-Border Health Services: Enhancing Information Provision to Patients

The overall objective of this study was to propose recommendations for improving the current level of information provision to patients by National Contact Points (NCPs). The research methodology used in this study consisted of: literature review, analysis of legal texts, website analysis, pseudo-patient investigation, NCP and patient surveys, bilateral exchanges and a workshop with NCPs. Core findings of the study are:

  • There is a general lack of awareness of the existence of the Directive 2011/24/EU and NCPs. Almost five years after the implementation of the Directive, patients awareness on their rights and possibilities to access health services abroad and on the existence of NCPs is still low;
  • The information provision through NCP websites was adequate, but there remains a need to further improve the websites. In particular, information on patient's rights, quality and safety standards, and reimbursement of cross-border healthcare costs require additional consideration and improvement;
  • There are big organisational differences between NCPs regarding the number of NCPs in each Member State, the institution hosting the NCP, funding and staff, and organisational handling of patients. Significant improvements have been achieved since the implementation of the Directive, however there is still room for further improvement;
  • Information provision for incoming patients is in general less complete compared to that for outgoing patients;
  • Overall, there is still ample room for improvement in NCP practices. There is especially great potential for NCPs to learn from each other and help each other improve their information provision to patients in the context of cross-border healthcare.

Download: Study on Cross-Border Health Services: Enhancing Information Provision to Patients (1.385 KB).

Download from eHealthNews.eu: Study on Cross-Border Health Services: Enhancing Information Provision to Patients (1.385 KB).

Most Popular Now

Researchers Capture First Images of Oxyg…

Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful. Hypoxia, or starvation of oxygen, in solid tumors is also thought to be...

VTT Makes New Investments in Digital Hea…

VTT is launching new research activities in the area of digital health as part of the growing wellbeing and health technology ecosystem in Kuopio. The new initiative aims to create...

A New Method of Artificial Intelligence …

Despite the immense progress in the field of AI in recent years, we are still very far from human intelligence. Indeed, if current AI techniques allow to train computer agents...

FDA Informs Health Care Providers, Facil…

Today, the U.S. Food and Drug Administration is issuing a safety communication informing health care providers, facilities and patients about cybersecurity vulnerabilities identified for certain GE Healthcare Clinical Information Central...

eHealthWeek 2020 Croatia - Trusted Infor…

15 - 17 April 2020, Rovinj, Croatia. In its capacity of hosting the upcoming Presidency of the Council of the European Union, the Croatian Ministry of Health is in preparations to...

Siemens Healthineers Presents Solutions …

CT scanners with intelligent user guidance, AI-based software assistants for MRI and a lab system that revolutionizes workflows: Siemens Healthineers is showcasing its products and solutions according to the motto...

NHS IT Chiefs Set the Stage for a Year o…

3 - 4 March 2019, London, United Kingdom. NHS technology leaders are to kick off the second-ever Digital Health Rewired Conference and Exhibition on 3 - 4 March at the Olympia...

PatchAi Startup has Arrived in the Marke…

PatchAi - a startup that offers, thanks to Artificial Intelligence and Machine Learning, an empathic virtual assistant to patients participating in clinical trials - announced that it has closed two...

Digital Health App Medicus AI Earns CE C…

Medicus AI, the Vienna-based health tech company, has received a ​Class I Medical Device CE Mark for its mobile application. The CE certification mark confirms that Medicus AI conforms to...

Refining Breast Cancer Classification by…

Breast cancer progression can vary significantly between patients. Even within the same tumor, different areas may be composed of different types of cells and characterized by different tumor structures. This...

Human Body-on-Chip Platform Enables In V…

Drug development is an extremely arduous and costly process, and failure rates in clinical trials that test new drugs for their safety and efficacy in humans remain very high. According...

FDA Authorizes Marketing of First Cardia…

Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images. The software, called Caption Guidance, is...